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Abstract Insulin receptor substrate-2-de¢cient (IRS-23/3)
mice develop type 2 diabetes. We have investigated the molec-
ular mechanisms by which IRS-23/3 immortalized brown adipo-
cytes showed an impaired response to insulin in inducing
GLUT4 translocation and glucose uptake. IRS-2-associated
phosphatidylinositol 3-kinase (PI 3-kinase) activity was blunted
in IRS-23/3 cells, total PI 3-kinase activity being reduced by
30%. Downstream, activation of protein kinase C (PKC) j was
abolished in IRS-23/3 cells. Reconstitution with retroviral IRS-
2 restores IRS-2/PI 3-kinase/PKCj signalling, as well as glu-
cose uptake. Wild-type cells expressing a kinase-inactive mutant
of PKCj lack GLUT4 translocation and glucose uptake. Our
results support the essential role played by PKCj in the insulin
resistance and impaired glucose uptake observed in IRS-2-de¢-
cient brown adipocytes.
3 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
One of the major metabolic functions of insulin is to stim-
ulate glucose uptake in adipose tissues and skeletal muscle
[1,2]. In these tissues insulin-induced glucose transport is
maintained through the translocation of the GLUT4 glucose
transporter to the cell surface. Since impaired insulin action in
peripheral tissues has been associated with defects in insulin
signalling molecules leading to glucose transport, over the last
years considerable work has been done to elucidate the mo-
lecular mechanisms regulating GLUT4 translocation. In this
regard, it is now generally accepted that phosphatidylinositol
3-kinase (PI 3-kinase) activation via its interaction with insu-
lin receptor substrates (IRSs) [3] plays an essential role [4^7].
In addition, downstream of PI 3-kinase two serine/threonine
kinases (PKB/Akt and atypical protein kinase C (PKC) j/V)
have been implicated as major transducer proteins of glucose
transport in response to insulin in di¡erent cell models [8^11].
However, recent ¢ndings indicating that insulin action as well
as its signalling seem to be tissue-speci¢c [12,13], make it
di⁄cult to assume that there is a unique pathway that medi-
ates GLUT4 translocation and glucose transport in insulin
target tissues.
Brown adipocytes have been extensively used to study mo-
lecular mechanisms of insulin action and inaction [14,15].
These cells display a large number of insulin receptors [16]
and activate the insulin signalling cascade under physiological
conditions [17]. Regarding glucose uptake, activation of both
Akt [18] and PKCj [19] by insulin has been shown to mediate
this metabolic e¡ect in primary cultures of fetal brown adipo-
cytes. More importantly, beside its short-term e¡ect on
GLUT4 translocation, insulin, in the long term, increased
GLUT4 and down-regulated GLUT1 gene expression in pri-
mary brown adipocytes, in a PI 3-kinase-dependent manner
[15].
On the other hand, upstream of PI 3-kinase, IRS-2 seems to
be crucial in mediating insulin-induced glucose uptake. Thus,
insulin responsiveness in induced glucose uptake was almost
impaired in immortalized brown pre-adipocytes derived from
IRS-2-de¢cient mice. In addition, in those cells an insulin-
induced e¡ect on GLUT4 translocation to the plasma mem-
brane was precluded [20]. Accordingly, we addressed the
underlying molecular mechanisms by which IRS-2 mediates
the insulin e¡ect on glucose uptake in IRS-2-de¢cient brown
adipocytes. Data shown herein propose that PI 3-kinase/
PKCj, but not the PI 3-kinase/Akt signalling pathway, is in-
hibited in IRS-2-de¢cient brown adipocytes upon insulin stim-
ulation. In addition, wild-type cells expressing a kinase-inac-
tive (KI) mutant of PKCj lack insulin responsiveness in
induced GLUT4 translocation and glucose uptake.
2. Materials and methods
2.1. Materials
Fetal calf serum, culture media and puromycin were obtained from
Gibco (Gaithersburg, MD, USA). Insulin, hygromycin, albumin,
polybrene and anti-mouse IgG-agarose were from Sigma (St. Louis,
MO, USA). Protein A-agarose was from Roche Molecular Biochem-
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icals. Anti-IRS-1 (06-248), anti-Tyr(P) (clone 4G10) (05-321), anti-
IRS-2 (06-506) were purchased from Upstate Biotechnology (Lake
Placid, NY, USA). Anti-phospho p70s6k (Ser424/Thr421 #9204S),
anti-p70s6k (#9202), anti-phospho Akt (Ser473 #9271), anti-Akt
(#9272), anti-phospho PKCj (Thr410 #9378) and anti-phospho
GSK-3K/L (Ser21/9 #9331) were purchased from Cell Signaling (Bev-
erly, MA, USA). Anti-PKCj antibody (c-20) (sc-216) and anti-Tyr(P)
(Py20) (sc-508) were purchased from Santa Cruz Biotechnology
(Palo Alto, CA, USA). [Q-32P]ATP (3000 Ci/mmol) and 2-deoxy-D-
[1-3H]glucose (11.0 Ci/mmol) were from Amersham (Aylesbury,
UK). All other reagents used were of the purest grade available.
2.2. Cell culture and retroviral infections
Brown adipocytes were obtained from interscapular brown adipose
tissue of 3-day newborn mice from crosses of IRS-2þ=3 parental mice.
Each brown adipose tissue from newborn genotypes, analyzed by
polymerase chain reaction, was subjected separately to collagenase
dispersion as previously described [21]. Viral Bosc packaging cells
were transfected at 70% con£uence by calcium phosphate coprecipi-
tation with 3 Wg/6-cm dish of the puromycin-resistant retroviral vector
pBABE encoding SV40 large T antigen (kindly provided by J. de
Caprio, Dana Farber Cancer Institute, Boston, MA, USA). Then,
primary brown adipocytes were infected at 60% con£uence with poly-
brene (4 Wg/ml)-supplemented virus for 48 h and maintained in culture
for 72 h, before selection with puromycin (1 Wg/ml) for 1 week. Cells
lines IRS-2þ=þ, IRS-2þ=3 and IRS-23=3 were expanded, the expres-
sion of IRS-2 being assessed by Western blot. To avoid variations
between littermates of the same genotype all the experiments were
performed in two di¡erent cell preparations.
2.3. Infection with adenoviral vectors
Adenoviral vectors encoding KI-PKCj or vector alone (mock) have
been previously described [22]. Wild-type brown adipocytes were rou-
tinely infected with 10 MOI (multiplicity of infection or viral particles
per cell) KI-PKCj, which after 48 h of incubation increased by
1.6-fold basal levels of PKCj (see below and [22]). Then, cells were
serum-starved for 12^15 h and subsequently used for determination of
PKCj activity or glucose transport, upon insulin stimulation.
2.4. Immunoprecipitations
Quiescent brown adipocytes (after 20 h of serum deprivation) were
treated without or with several doses of insulin as indicated, and lysed
at 4‡C in bu¡er containing 10 mM Tris^HCl, 5 mM EDTA, 50 mM
NaCl, 30 mM sodium pyrophosphate, 50 mM NaF, 100 WM Na3VO4,
1% Triton X-100, and 1 mM phenylmethylsulfonyl £uoride, pH 7.6
(lysis bu¡er). After protein content determination, equal amounts of
protein (500^600 Wg) were immunoprecipitated at 4‡C with the corre-
sponding antibodies. The immune complexes were collected on pro-
tein A-agarose or anti-mouse IgG-agarose beads. Immunoprecipitates
were washed with lysis bu¡er and analyzed by SDS^PAGE followed
by Western blotting.
2.5. PI 3-kinase activity
PI 3-kinase activity was measured in the anti-IRS-1, anti-IRS-2 and
anti-Tyr(P) immunoprecipitates by in vitro phosphorylation of phos-
phatidylinositol as previously described [19].
2.6. PKCj activity
PKCj activity was measured in anti-PKCj immune complexes by in
vitro phosphorylation of myelin basic protein (MBP) as previously
described [19].
2.7. Subcellular fractionation
Cells were washed with ice-cold phosphate-bu¡ered saline and
scraped in homogenization bu¡er containing 20 mM Tris^HCl, pH
7.4, 2 mM EGTA, 2 mM EDTA, 1 mM phenylmethylsulfonyl £uo-
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Fig. 1. IRS expression and tyrosine phosphorylation in wild-type, heterozygous and IRS-2-de¢cient brown adipocytes. Brown adipocyte cell
lines were cultured under growing conditions. Total protein was subjected to SDS^PAGE and analyzed by Western blot with the anti-IRS-2
antibody. Two di¡erent cell lines from each genotype were analyzed. Serum-starved brown adipocytes (IRS-2þ=þ, IRS-2þ=3 and IRS-23=3)
were incubated for 5 min without or with various doses of insulin (10^100 nM). Cells were lysed and total protein was immunoprecipitated
with anti-IRS-2 or anti-IRS-1 antibodies, subjected to SDS^PAGE and analyzed by Western blot with the anti-Tyr(P), anti-IRS-2 and anti-
IRS-1 antibodies. The autoradiograms corresponding to three independent experiments were quantitated by scanning densitometry. Results are
expressed as arbitrary units of IRS-1 and IRS-2 tyrosine phosphorylation and are meansUS.E.M.
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ride, 10 mM L-mercaptoethanol, 10 Wg/ml aprotinin and 10 Wg/ml
leupeptin. After 10 min incubation cells were homogenized with 30
strokes of a Dounce homogenizer using a tight-¢tting pestle. Nuclei
were collected by centrifugation at 500Ug for 5 min, and the low
speed supernatant was centrifuged at 100 000Ug for 30 min. The
high speed supernatant constituted the internal membrane fraction.
The pellet was washed three times and extracted in ice-cold homoge-
nization bu¡er containing 1% Triton X-100 for 60 min. The Triton-
soluble component (plasma membrane fraction) was separated from
the Triton-insoluble material (cytoskeletal fraction) by centrifugation
at 100 000Ug for 15 min. Plasma membrane fractions were kept at
370‡C before protein quanti¢cation and Western blotting with anti-
bodies against GLUT4 and L-actin.
2.8. Measurement of glucose transport
Quiescent cells after 20 h of serum deprivation in 5 mM glucose
DMEM medium were treated with or without insulin for 10 min.
Glucose transport was measured as 2-deoxy-D[1-3H]glucose uptake
in triplicate dishes from three independent experiments as previously
described [19].
2.9. Protein determination
Protein determination was performed by the Bradford dye method
[23], using the Bio-Rad reagent and bovine serum albumin as the
standard.
3. Results and discussion
3.1. The tyrosine phosphorylation cascade in wild-type and
IRS-2-de¢cient brown adipocytes
We have generated immortalized brown adipocyte cell lines
derived from individual brown adipose tissue of 3-day-old
newborn wild-type, heterozygous and IRS-2-de¢cient mice.
As shown in Fig. 1, cell lines derived from homozygous
mice (IRS-23=3 ; N5 and N6) had no immunoreactive IRS-2
protein, whereas cell lines derived from heterozygous mice
(IRS-2þ=3 ; N3 and N4) showed a 50% reduction in IRS-2
expression as compared to the cell lines derived from the
wild-type mice (IRS-2þ=þ ; N1 and N2). To assess the tyrosine
phosphorylation of both IRS-1 and IRS-2 in the three cell
types, brown adipocytes were serum-starved and stimulated
with insulin (10^100 nM). Then, cell lysates were immunopre-
             
             
                        
                           
   
         
Fig. 2. PI 3-kinase activity and its downstream e¡ectors in insulin-stimulated wild-type and IRS-2-de¢cient brown adipocytes. A: Serum-starved
brown adipocytes (IRS-2þ=þ, IRS-2þ=3 and IRS-23=3) were incubated for 5 min without or with various doses of insulin (10^100 nM). Cells
were lysed and total protein was immunoprecipitated with anti-IRS-2, anti-IRS-1 and anti-Tyr(P) antibodies. The resulting immune complexes
were washed and immediately used for an in vitro phosphatidylinositol kinase assay. The conversion of phosphatidylinositol to phosphatidyl-
inositol phosphate in the presence of [Q-32P]ATP was analyzed by thin-layer chromatography. The autoradiograms corresponding to three inde-
pendent experiments were quantitated by scanning densitometry. Results are expressed as arbitrary units of PI 3-kinase and are meansUS.E.M.
B: Lysates of insulin-stimulated cells were subjected to SDS^PAGE and analyzed by Western blot with the anti-phospho-Akt, anti-Akt, anti-
phospho-GSK-3K/L, anti-phospho-p70s6k, anti-p70s6k, anti-phospho-PKCj and anti-PKCj antibodies. The results shown are representative of
at least three independent experiments.
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cipitated with the corresponding anti-IRS-1 and anti-IRS-2
antibodies and the resulting immunocomplexes were analyzed
by Western blot with the anti-Tyr(P) antibody. Wild-type
brown adipocytes showed a marked increase in tyrosine phos-
phorylation of IRS-2 upon insulin stimulation, the maximal
e¡ect being elicited at 100 nM insulin concentration (Fig. 1).
As expected, no tyrosine-phosphorylated IRS-2 was found in
IRS-23=3 cells, a 50% reduction of IRS-2 phosphorylation
being observed in IRS-2þ=3 cell lines. Conversely, both IRS-
1 expression and its tyrosine phosphorylation upon insulin
stimulation did not change among the three cell types studied.
Likewise, insulin receptor L-chain tyrosine phosphorylation
was not a¡ected by the lack of IRS-2 (results not shown).
Our data clearly suggest that the lack of IRS-2 did not result
in an increased IRS-1 expression nor in an enhanced tyrosine
phosphorylation, upon insulin stimulation. This lack of com-
pensation contrasts with the signalling in IRS-1-de¢cient
brown adipocytes, where we observed an increased content
and tyrosine phosphorylation of IRS-2 in response to insulin
[24,25]
3.2. Insulin e¡ect on PI 3-kinase activity and its downstream
e¡ectors in wild-type and IRS-2-de¢cient brown adipocytes
In insulin-stimulated primary brown adipocytes, PI 3-kinase
is activated by an interaction of the p85 regulatory subunit
with tyrosine-phosphorylated IRS-1 and IRS-2 [17]. To study
whether this interaction is a¡ected by the absence of IRS-2,
we measured IRS-2- and IRS-1-associated PI 3-kinase activity
in the three cell types stimulated with various doses of insulin.
IRS-2-associated PI 3-kinase activity was completely blunted
in IRS-23=3 brown adipocytes (Fig. 2A). Conversely, in these
cells IRS-1-associated PI 3-kinase activity upon insulin stim-
ulation was similar to that of the wild-type. In order to assess
the relative contributions of IRS proteins to the total activa-
tion of PI 3-kinase, we measured this activity in anti-Tyr(P)
immunoprecipitates. As shown in Fig. 2A, the amount of total
PI 3-kinase recovered in IRS-2-de¢cient cells was reduced by
30% as compared to the wild-type. These data con¢rm the
results seen above showing the lack of compensatory signal-
ling through IRS-1/PI 3-kinase.
Next, we analyzed how the lack of IRS-2 worked on PI
3-kinase downstream signalling. Neither Akt phosphorylation
(measured by direct Western blot analysis with the anti-phos-
pho-Akt Ser473 antibody) nor GSK-3 phosphorylation (K and
L isoforms) was altered in IRS-23=3 cells, upon insulin
stimulation. Likewise, p70S6k phosphorylation remained un-
changed in insulin-stimulated IRS-23=3 cells as compared to
the wild-type. However, the phosphorylation of PKCj (mea-
sured by Western blot analysis with the anti-phospho-PKCj-
Thr410 antibody), which was stimulated by insulin in primary
[19] and immortalized wild-type brown adipocytes, was com-
pletely precluded in IRS-2-de¢cient cells (Fig. 2B). These data
are entirely consistent with those results observed in L6hIR
muscle cells overexpressing a peptide corresponding to the
KRLB domain of IRS-2 [26]. In fact, these cells did not stim-
ulate IRS-2 phosphorylation and PKCj activity in response to
 
Fig. 3. PKCj activity is severely decreased in insulin-stimulated IRS-2-de¢cient brown adipocytes. Upper panel (left): IRS-23=3 brown adipo-
cytes were infected with a retroviral vector encoding IRS-2. Hygromycin-resistant clones were expanded and cell lysates were analyzed by West-
ern blot with anti-IRS-2 antibody. (right) Wild-type cells were infected with adenoviruses encoding KI-PKCj (10 MOI) or vector alone (mock)
for 48 h. Total cell lysates were analyzed by Western blot with anti-PKCj antibody. Lower panel: Cells were serum-starved for 12^15 h and
further stimulated as described in Fig. 2. Cell lysates were immunoprecipitated with the anti-PKCj antibody and assayed for PKCj activity.
The autoradiograms of MBP phosphorylation were quantitated by scanning densitometry. Results are normalized with the amount of total
PKCj and are expressed as arbitrary units of PKCj activity. Statistical analysis of meansUS.E.M. of four to six determinations is indicated,
*P6 0.05.
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insulin. Furthermore, the impairment of IRS-2/PKCj signal-
ling resulted in a reduced phosphorylation of Akt and GSK-
3K and L, with the outcome of an impaired glycogen synthesis
in response to insulin. However, our data in brown adipocytes
suggest a diverging signalling downstream of IRS-2/PI
3-kinase through PKCj or alternatively through Akt/GSK-3K
and L.
3.3. PKCj activity mediates insulin-induced glucose transport
in brown adipocytes
The fact that IRS-2-de¢cient cells did not respond to insulin
regarding PKCj phosphorylation in the threonine 410 residue
prompted us to measure its enzymatic activity. As shown in
Fig. 3 (lower panel), insulin induced PKCj activity in wild-
type brown adipocytes, this e¡ect being totally blunted in the
absence of IRS-2. To assess these data, we reconstituted IRS-
2 expression in de¢cient cells by means of retroviral gene
transfer. The Western blot depicted in Fig. 3 (upper left panel)
shows that the reconstitution of IRS-2 expression represents
50^60% of the level seen in wild-type cells. IRS-2-reconsti-
tuted brown adipocytes (rec-IRS-2) activated PKCj in parallel
with the level of IRS-2 protein expressed, upon insulin stim-
ulation. In addition, we expressed a KI mutant of PKCj [22]
in wild-type cells by means of adenoviral gene transfer (Fig. 3,
upper right panel). Whereas PKCj activity was induced by
insulin in control cells (mock-infected), KI-PKCj-infected
cells completely lack the insulin e¡ect in activating this en-
zyme (Fig. 3, lower panel). Taken together, these results in-
dicate that IRS-2 mediates the activation of PKCj by insulin
in brown adipocytes, IRS-1 being unable to compensate this
response.
Our laboratory has recently demonstrated an essential con-
tribution of PKCj to the insulin action regarding glucose
transport in brown adipocyte primary cultures [19]. Based
on that, we measured glucose uptake in insulin-stimulated
wild-type, IRS-23=3 and rec-IRS-2 brown adipocytes. The
results shown in Fig. 4A indicate that insulin-induced glucose
transport in brown adipocytes parallels PKCj activation.
Whereas wild-type cells induced a 2.5-fold increase in glucose
transport upon insulin stimulation, IRS-2-de¢cient cells were
unable to respond to the hormone. Moreover, the reconstitu-
tion of IRS-2-de¢cient brown adipocytes recovered the acti-
vation of glucose transport upon insulin treatment in parallel
to the recovery of both IRS-2 and PKCj enzymatic activity.
These data show that IRS-2 is an essential player in stimulat-
ing glucose transport in response to insulin in brown adipo-
 
 
                                
 
       
              
Fig. 4. E¡ect of the lack of IRS-2 or adenovirus encoding KI-PKCj on basal and insulin-stimulated glucose uptake in brown adipocytes.
A: Brown adipocytes (IRS-2þ=þ, IRS-23=3 and rec-IRS-2) were serum-starved for 12^15 h in 5 mM glucose DMEM medium and further
stimulated with 100 nM insulin. Wild-type or primary brown adipocytes were infected with 10 MOI of the adenoviruses encoding KI-PKCj or
vector alone (mock). After 48 h, cells were serum-starved in 5 mM glucose DMEM medium for 12^15 h and further stimulated with 100 nM
insulin. Glucose uptake was measured as described in Section 2. Results are shown as the averageUS.E.M. (nv 4). Unpaired Student’s t-tests
were used for analysis of di¡erences between various cell lines; *P6 0.05 is considered signi¢cant. B: Cells were treated as described above and
collected for subcellular fractionation. 10 Wg of internal and plasma membrane proteins of each condition were subjected to SDS^PAGE and
analyzed by Western blot with the anti-GLUT4 and L-actin antibodies. A representative experiment is shown. The autoradiograms correspond-
ing to three independent experiments were quantitated by scanning densitometry. Results are expressed as arbitrary units of GLUT4 in the
plasma membrane and are meansUS.E.M.
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cytes, as was previously reported in brown pre-adipocytes [20].
However, it has recently been demonstrated that either exer-
cise or insulin-induced glucose transport in the skeletal muscle
of IRS-2 knockout mice is not altered [27], illustrating the
tissue speci¢city of the insulin action.
The above-described ¢ndings suggest that alterations in
IRS-2-mediated PKCj activation could result in the inhibition
of insulin-stimulated glucose uptake. To directly address this
point, we infected both immortalized and primary wild-type
brown adipocytes with adenoviruses encoding KI-PKCj.
Then, cells were serum-starved, stimulated with 100 nM insu-
lin and 2-deoxyglucose uptake was measured. As shown in
Fig. 4A, insulin induced glucose transport in wild-type cell
lines as well as in primary brown adipocytes. This e¡ect was
totally abolished in either established or primary cells infected
with KI-PKCj, but not in the mock cells. Finally, we ad-
dressed whether the decrease in insulin-stimulated glucose
transport was caused by impaired GLUT4 translocation
from the internal stores to the plasma membrane fraction.
For this purpose, IRS-2-de¢cient and wild-type cells (mock
or infected with KI-PKCj) were stimulated with 100 nM in-
sulin and subjected to subcellular fractionation as described in
Section 2. The Western blot depicted in Fig. 4B revealed that
insulin failed to translocate GLUT4 to the plasma membrane
in brown adipocytes lacking IRS-2 and in wild-type cells ex-
pressing KI-PKCj, but not in the wild-type or mock cells.
These data emphasize the essential role played by IRS-2
through PKCj in mediating GLUT4 translocation to the plas-
ma membrane in response to insulin, and are fairly consis-
tent with those previously reported in rat adipose cells [28].
More importantly, this association between IRS-2/PKCj and
GLUT4 translocation/glucose transport in response to insulin
in brown adipocytes allows us to understand the defective
IRS-2 phosphorylation and an impaired PKCj activation in
skeletal muscle from obese patients showing insulin resistance
and glucose intolerance [29].
In conclusion, our data strongly support the essential role
played by PKCj in the insulin resistance and impaired glucose
uptake observed in IRS-2-de¢cient brown adipocytes.
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